as on February 2, 2026 at 4:01 pm IST
Day's Low
Day's High
5.98%
Downside
8.58%
Upside
52 Week's Low
52 Week's High
22.22%
Downside
33.32%
Upside
as on February 2, 2026 at 4:01 pm IST
Market Cap
₹1,751.41 Cr
Return on Equity (ROE)
12.69
PE Ratio (TTM)
25.86
Return on capital employed (ROCE)
16.79
Industry PE ratio
40.1
Beta (LTM)
1.26
P/B Ratio
4.31
Dividend Yield
0.56
PEG Ratio
9.44
Quarterly Earnings Growth YOY
13.67
EPS (TTM)
29.1
Sector
Pharmaceuticals
Book Value
241.3
Technical Analysis
Bullish
View Technical Analysis
as on February 2, 2026 at 4:01 pm IST
Windlas Biotech in the last 5 years
Lowest (10.46x)
March 28, 2023
Today (25.86x)
February 1, 2026
Industry (40.10x)
February 1, 2026
Highest (38.93x)
December 6, 2024
Today’s Price to Earnings Ratio: 25.86x
Compare market cap, revenue, PE, and other key metrics of Windlas Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,751.41 | 20.82% | 0.53 | 60 | 759 | |
| NA | 470.99 | 12.24% | 0.00 | 13 | 104 | |
| NA | 3,028.53 | 29.23% | 0.69 | 69 | 819 | |
| NA | 74.97 | 20.48% | 0.98 | 2 | 405 | |
| NA | 31.29 | -4.93% | 0.78 | -13 | 92 |
Get share price movements and forecasts by analysts on Windlas Biotech.
Source: S&P Global Market Intelligence
Search interest for Windlas Biotech Ltd Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:3% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Windlas Biotech.
Windlas Biotech Ltd’s net profit jumped 13.67% since last year same period to ₹17.80Cr in the Q2 2025-2026. On a quarterly growth basis, Windlas Biotech Ltd has generated 0.79% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Windlas Biotech Ltd has declared dividend of ₹5.80 per share on 22 May 2025 - translating a dividend yield of 0.70%.
Read More about DividendsCheck stock indices that include Windlas Biotech.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
![]()
Mutual Funds have increased holdings from 6.39% to 6.63% in Dec 2025 quarter
Revenue Rich
![]()
Revenue is up for the last 12 quarters, 121.87 Cr → 226.04 Cr (in ₹), with an average increase of 5.4% per quarter
Best in 3 Years
![]()
In the last 3 years, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
![]()
In the last 7 days, WINDLAS stock has moved up by 7.9%
Retail Holding Up
![]()
Retail Investor have increased holdings from 25.47% to 25.64% in Dec 2025 quarter
Profit Spike
![]()
Netprofit is up for the last 4 quarters, 15.58 Cr → 17.8 Cr (in ₹), with an average increase of 4.3% per quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 26.1% return, outperforming this stock by 40.0%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 61.99% of holdings in Dec 2025 quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 1.11% to 0.93% in Dec 2025 quarter
| Organisation | Windlas Biotech Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| CEO | Vivek Dhariwal |
| E-voting on shares | Click here to vote |
Windlas Biotech share price today stands at ₹855.1 as on at the close of the market. Windlas Biotech share today touched a day high of ₹928.5 and a low of ₹804.
Windlas Biotech touched a 52 week high of ₹1140 and a 52 week low of ₹665.1. Windlas Biotech share price today i.e. is closed at ₹855.1, which is -24.99% down from its 52 week high and 28.57% up from its 52 week low.
Windlas Biotech market capitalisation is ₹1,751.41 Cr as on .
To buy Windlas Biotech shares, you need to follow these steps:
Windlas Biotech trading volume is 69.02K as on . This means that 69.02K shares of Windlas Biotech were bought and sold on the stock market during today's trading session.